Market Tracker

07/27 5:16pm ET

Cynosure Inc (NASDAQ:CYNO)

53.92
Delayed Data
As of Jul 27
 -0.33 / -0.61%
Today’s Change
29.00
Today|||52-Week Range
55.94
+20.71%
Year-to-Date
Illumina (ILMN) Beats Q2 Earnings, Revenues; EPS View Up
Jul 27 / Zacks.com - Paid Partner Content
Cynosure (CYNO) Reaches New Lifetime High Today
Jul 26 / TheStreet.com - Paid Partner Content
Edwards Lifesciences (EW) Tops Q2 Earnings, '16 View Up
Jul 27 / Zacks.com - Paid Partner Content
Med-Instrument Stocks to Post Earnings: EW, CYNO, GMED
Jul 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close54.25
Today’s open54.90
Day’s range52.99 - 54.98
Volume328,620
Average volume (3 months)343,587
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)-50.35%
Earnings growth (this year)+19.14%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+16.11%
P/E ratio66.5
Price/Sales2.98
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
XLRNAcceleron Pharma Inc+1.78+5.45%
CNMDConmed Corp-0.16-0.33%
PCRXPacira Pharmaceutica...+0.21+0.57%
PTLAPortola Pharmaceutic...+0.78+3.10%
Data as of 3:59pm ET, 07/27/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.26
Annual revenue (last year)$339.5M
Annual profit (last year)$15.8M
Net profit margin4.66%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Davin
Chief Operating &
Financial Officer
Timothy W. Baker
Corporate headquarters
Westford, Massachusetts

Forecasts